Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Semler Scientific ( (SMLR) ) is now available.
On September 22, 2025, Semler Scientific and Strive, Inc. announced a merger agreement where Strive will acquire Semler in an all-stock transaction. This merger, approved by both companies’ boards, is expected to enhance Strive’s position as a leading Bitcoin treasury company and expand Semler’s diagnostics business into preventative care. The transaction includes a significant premium for Semler’s stockholders and aims to drive shareholder value through innovative Bitcoin strategies and expanded healthcare services.
The most recent analyst rating on (SMLR) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Spark’s Take on SMLR Stock
According to Spark, TipRanks’ AI Analyst, SMLR is a Neutral.
Semler Scientific’s overall stock score reflects a mix of strong strategic initiatives and financial challenges. The company’s robust Bitcoin strategy and stable balance sheet are positive factors, but declining revenues and bearish technical indicators weigh on the score. The valuation is reasonable, but the lack of a dividend yield is a drawback for some investors.
To see Spark’s full report on SMLR stock, click here.
More about Semler Scientific
Semler Scientific, Inc. is a leader in medical devices and software aimed at combating chronic diseases, with a focus on early detection and monitoring. Their flagship product, QuantaFlo, is FDA-cleared and aids in diagnosing peripheral arterial disease. Semler Scientific also adopts Bitcoin as a primary treasury reserve asset.
Average Trading Volume: 715,575
Technical Sentiment Signal: Sell
Current Market Cap: $432M
Learn more about SMLR stock on TipRanks’ Stock Analysis page.